Upload Records Snowball Search Search OpenAlex
About the database ScholarIQanswers from OpenAlex & ORCID
How has Holly B. Krasa's publication output changed over time?
ScholarIQpublication output · 1997–2023
Output grew0% over the shown period — from 1 works in 1997 to 1 in 2023.
1
1
2
2
1
1
1
1
1
199720002008201120122013201520162023
What are the most-cited papers on Holly B. Krasa?
ScholarIQmost cited works
Tolvaptan in Patients with Autosomal Dominant Polycystic Kidney Disease
Vicente E. Torres, Arlene B. Chapman, Olivier Devuyst, Ron T. Gansevoort, Jared J. Grantham, Eiji Higashihara, Ronald D. Perrone, Holly B. Krasa, John Ouyang, Frank S. Czerwiec
New England Journal of Medicine. 20121,606 CitationsOPEN ACCESS
Prevalence of autosomal dominant polycystic kidney disease in the European Union
Cynthia Willey, Jaime D. Blais, Anthony K Hall, Holly B. Krasa, Andrew Makin, Frank S. Czerwiec
Nephrology Dialysis Transplantation. 2016246 CitationsOPEN ACCESS
Clinical Pattern of Tolvaptan-Associated Liver Injury in Subjects with Autosomal Dominant Polycystic Kidney Disease: Analysis of Clinical Trials Database
Paul B. Watkins, James H. Lewis, Neil Kaplowitz, David Alpers, Jaime D. Blais, Dan M. Smotzer, Holly B. Krasa, John Ouyang, Vicente E. Torres, Frank S. Czerwiec, Christopher A. Zimmer
S49488433. 2015195 CitationsOPEN ACCESS
Acute Hemodynamic Effects of Tolvaptan, a Vasopressin V2 Receptor Blocker, in Patients With Symptomatic Heart Failure and Systolic Dysfunction
James E. Udelson, Cesare Orlandi, John Ouyang, Holly B. Krasa, Christopher A. Zimmer, Geir Frivold, W. Herbert Haught, Sheiba Meymandi, Cezar Macarie, Dimitar Raef, Patricia Wedge, Marvin A. Konstam, Mihai Gheorghiade
Journal of the American College of Cardiology. 2008182 CitationsOPEN ACCESS
Continental Differences in Clinical Characteristics, Management, and Outcomes in Patients Hospitalized With Worsening Heart Failure
John E. Blair, Faı̈ez Zannad, Marvin A. Konstam, Thomas D. Cook, Brian Traver, John C. Burnett, Liliana Grinfeld, Holly B. Krasa, Aldo P. Maggioni, Cesare Orlandi, Karl Swedberg, James E. Udelson, Christopher Zimmer, Mihai Gheorghiade
Journal of the American College of Cardiology. 2008175 Citations
Related on ScholarIQ
ActionAid
Institution
Tolvaptan in Patients with Autosomal Dominant Polycystic Kidney Disease
Paper
Prevalence of autosomal dominant polycystic kidney disease in the European Union
Paper
Clinical Pattern of Tolvaptan-Associated Liver Injury in Subjects with Autosomal Dominant Polycystic Kidney Disease: Analysis of Clinical Trials Database
Paper
Acute Hemodynamic Effects of Tolvaptan, a Vasopressin V2 Receptor Blocker, in Patients With Symptomatic Heart Failure and Systolic Dysfunction
Paper
Continental Differences in Clinical Characteristics, Management, and Outcomes in Patients Hospitalized With Worsening Heart Failure
Paper